Filanesib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Filanesib, covering 2020-10-19 to 2022-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients [Phase 1, Phase 2]